TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial.

Monika Graeser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.